Trial Profile
Prospective, randomized, open-label, clinical trial comparing the effects of sitagliptin and alogliptin on postprandial glucose/lipids metabolism and endothelial function in diabetic patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary) ; Sitagliptin (Primary)
- Indications Diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 10 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 03 Jun 2011 New trial record